The National Institutes of Health (NIH) announces a unique opportunity for investigators working with small molecule compounds to gain access to a robust ‘virtual pharma’ drug development network to develop neurotherapeutic drugs. Successful applicants to this FOA will become collaborative participants in this network, receiving both funding and no-cost access to contracted drug development services that are not typically available to the academic research community.